Decision to list laboratory equipment and consumables supplied by Olympus New Zealand Limited
We are pleased to announce the approval of listing agreements for the supply of medical devices to DHBs.
What we’re doing
We are pleased to announce the approval of a listing agreement with Olympus New Zealand Limited (“Olympus”) for the supply of laboratory equipment and consumables to DHBs.
In summary this will result in:
- Olympus’ laboratory equipment and consumables being listed in Part III of Section H of the Pharmaceutical Schedule from 1 August 2021 under a national agreement that all DHBs may purchase under (“Agreement”); and
- DHBs being able to continue to purchase other suppliers’ brands of laboratory equipment and consumables.
Any changes to the original proposal?
This decision was subject to a consultation letter dated 8 June 2021.
There were no changes made to the Agreement as a result of the consultation feedback.
Who we think will be most interested
- DHB Staff
- Clinical Engineers and maintenance services
- Clinical Product Evaluators
- Clinicians
- Laboratory managers, scientists, technicians and other laboratory staff
- Pathologists
- Procurement Officers and supply chain personnel
- Suppliers and wholesalers
Details about this decision
In September 2018, Pharmac issued a Request for Proposal (“RFP”) for the supply of laboratory equipment and consumables for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFP to seek provisional agreements and this is the first proposal to be contracted as a result of the laboratory equipment and consumables RFP. We are continuing to negotiate contracts with other suppliers of laboratory equipment and consumables.
DHBs can continue to choose which laboratory equipment and consumables they purchase, including those from other suppliers. DHBs that purchase laboratory equipment and consumables from Olympus must do so under the terms and conditions, including pricing, in the Pharmac Agreement from 1 August 2021.
This proposal is the first agreement to arise from this process and we expect to consult on further provisional agreements with suppliers of laboratory equipment and consumables throughout 2021.
Our response to what you told us
We appreciate the time people took to respond to this consultation.
All consultation responses received by 5 July 2021 were considered in their entirety in making the decision to list Olympus’ laboratory equipment and consumables.
A summary of the main themes raised in feedback and our responses to the feedback are set out below:
|
Theme |
Comment |
|---|---|
|
No technical or resource impacts anticipated as a result of the proposal. |
Noted. |
|
Query about the savings in the confidential financial impact analysis provided to DHB Procurement Managers. |
Clarification was sought from the supplier and updated information has been provided to DHB Procurement Managers. |
| Support and endorsement for the proposal as it is not for sole supply of laboratory equipment and consumables. | Noted. |
If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.